Alpha 1-antitrypsin: a possible tool for diagnosis of cervical cancer.
The serum protease inhibitor alpha 1-AT was measured in patients with different types of cancer and compared with that of normal human serum. alpha 1-AT levels, as measured by its trypsin inhibitory capacity and the immunodiffusion technique, showed significant increase (P less than 0.05 and P less than 0.001, respectively) in cervical cancer patients. The results indicates that levels of alpha 1-AT may have a direct relationship with cervical cancer condition.